BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31358793)

  • 21. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
    Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I
    Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JBPOS0101 attenuates amyloid-β accumulation and memory loss in a mouse model of Alzheimer's disease.
    Park HJ; Jang JK; Choi YM; Choi WS
    Neuroreport; 2019 Jul; 30(10):741-747. PubMed ID: 31095107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.
    Lei M; Teo JD; Song H; McEwen HP; Yup Lee J; Couttas TA; Duncan T; Chesworth R; Bertz J; Przybyla M; Van Eersel J; Heng B; Guillemin GJ; Ittner LM; Fath T; Garner B; Ittner A; Karl T; Don AS
    J Neurosci; 2019 Nov; 39(48):9645-9659. PubMed ID: 31641049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
    Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
    Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
    Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
    ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model.
    Jeong J; Park HJ; Mun BR; Jang JK; Choi YM; Choi WS
    PLoS One; 2020; 15(8):e0237153. PubMed ID: 32791516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
    Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
    J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.
    Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y
    Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.
    Medrano-Jiménez E; Jiménez-Ferrer Carrillo I; Pedraza-Escalona M; Ramírez-Serrano CE; Álvarez-Arellano L; Cortés-Mendoza J; Herrera-Ruiz M; Jiménez-Ferrer E; Zamilpa A; Tortoriello J; Pedraza-Alva G; Pérez-Martínez L
    J Neuroinflammation; 2019 Jul; 16(1):143. PubMed ID: 31291963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons.
    Joshi P; Gabrielli M; Ponzoni L; Pelucchi S; Stravalaci M; Beeg M; Mazzitelli S; Braida D; Sala M; Boda E; Buffo A; Gobbi M; Gardoni F; Matteoli M; Marcello E; Verderio C
    Sci Rep; 2017 Jan; 7():41734. PubMed ID: 28134307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice.
    ElAli A; Bordeleau M; Thériault P; Filali M; Lampron A; Rivest S
    Neuropsychopharmacology; 2016 Apr; 41(5):1297-307. PubMed ID: 26349911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.
    Dorey E; Bamji-Mirza M; Najem D; Li Y; Liu H; Callaghan D; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Alzheimers Dis; 2017; 57(4):1265-1279. PubMed ID: 28372324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
    Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
    Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.